Onconetix (NASDAQ: ONCO - Get Free Report) and Celularity (NASDAQ: CELU - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, earnings and institutional ownership. Volatility and Risk Onconetix has a beta of 2.62,